摘要
前列腺癌(prostate cancer,PCa)放射性粒子近距治疗近年在国外发展迅速,因方法简便、疗效显著,已成为治疗早期PCa的一种行之有效的选择。
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
2007年第4期285-287,共3页
Chinese Journal of Urology
参考文献27
-
1Nag S,Beyer D,Friedland J,et al. American Brachytherapy Society (ABS)re-commendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys,1999,44:789-799.
-
2Ragde H, Grado GL, Nadir B, et al.Mo-dern prostate brachytherapy. CA Cancer J Clin, 2000,50: 380-393.
-
3Ove R, Wallner K, Badiozamani K, et al. Standardization of prostate brachy-therapy treatment plans. Int J Radiat Oncol Biol Phys, 2001,50 : 257-263.
-
4Consensus statement: guidelines for PSA following radiation therapy. A-merican Society for Therapeutic Radiology and Oncology Consensus Panel.Int J Radiat Oncol Biol Phys, 1997,37:1035-1041.
-
5Cavanagh W,Blasko JC,Grimm PD,et al. Transient elevation of serum prostate-specific antigen following (125) I/(103) Pd brachytherapy for localized prostate cancer. Semin Urol Oncol,2000,18:160-165.
-
6Potters L, Morgenstern C, Calugaru E, et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol,2005,173:1562-1566.
-
7王国民,徐志兵,朱延军,徐叶青,陈绍亮,曾昭冲,程文英.^(125)I放射性粒子永久植入治疗前列腺癌[J].中华泌尿外科杂志,2005,26(4):263-266. 被引量:18
-
8黄毅,马潞林,王俊杰,冉维强.^(125)I放射粒子植入治疗激素难治性前列腺癌[J].中华泌尿外科杂志,2004,25(10):701-703. 被引量:18
-
9D'Amico AV, Whittington R, Malkowicz SB,et al. Biochemical outcome after radical prostatectomy, external beamradiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, 1998, 280:969-974.
-
10Sharkey J, Cantor A, Solc Z, et al. ^103 Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer:a 12-year experience from a single group practice.Brachytherapy, 2005,4 : 34-44.
二级参考文献21
-
1Holm HH, Stroyer I, Hansen H, et al. Ultrasonically guided percutaneous interstitial implantation of iodine 125 seeds in cancer therapy.Br J Radiol,1981,54 :665.
-
2Ragde H ,Grado GL,Nadir BS. Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone.Arch Esp Urol,2001,54:739-747.
-
3Sharkey, Cantor A, Solc Z, et al. Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer. Curr Urol Rep ,2002,3:250-257.
-
4Anonymous. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys, 1997,37 :1035-1041.
-
5Iannuzzi CM,Stock RG,Stone NN. PSA kinetics following 1-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer. Radiat Oneol Investig, 1999,7:30-35.
-
6Chauveinc L, Flare T, Solignac S, et al. Indications for curietherapy of the prostate using permanent implants. Cancer Radiothcr, 2002,6 :154-158.
-
7Kucway R,Vicini F, Huang R, et al. Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol,2002 ,167 :2443-2447.
-
8Kleinberg L, Wallner K, Roy J, et al. Treatment- related symptoms during the first year following transperineal I- 125 prostate implantation. Int J Radiat Oncol Biol Phys, 1994,28:985-990.
-
9Wallner K, Boy J, Harrison L. Low risk of perioperative infection without prophylactic for transperineal prostate brachytherapy. Int J Badiat Oncol Biol Phys, 1996,36:681-683.
-
10Tapen EM, Blasko JC, Grimm PD, et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oneol Biol Phys,1998,42:1063-1067.
共引文献32
-
1黄振国,张雪哲,王武,洛小林,王继英.CT导引下^(125)I粒子植入治疗外照射后复发的恶性肿瘤[J].临床放射学杂志,2006,25(3):269-272. 被引量:3
-
2李洪均.放射性粒子植入治疗恶性肿瘤[J].医学综述,2007,13(5):361-363. 被引量:3
-
3程文,申宝忠,崔亚利,王雷.超声介导^(125)I放射性粒子植入治疗晚期恶性肿瘤[J].中国超声医学杂志,2007,23(4):308-310. 被引量:2
-
4洪锴,黄毅,马潞林,王俊杰,冉为强.^(125)I前列腺放射粒子植入术并发症分析[J].中国肿瘤临床与康复,2007,14(2):125-128.
-
5袁晓红,张晓林,赵静燕.放射性微粒子^(125)I植入治疗前列腺癌的护理[J].实用临床医药杂志(护理版),2007,3(4):13-14. 被引量:1
-
6徐文峰,林哲,杨明,张海滨,冯彦林,余丰文,刘建华,叶珊.^(125)Ⅰ粒子前列腺永久性组织间植入治疗前列腺癌16例[J].广东医学,2007,28(12):1941-1943.
-
7宋婷婷,刘希光,杜利力,梁军.^(125)I粒子组织间植入对小鼠Lewis肺癌Egr-1及caspase-3表达的影响[J].临床肿瘤学杂志,2008,13(3):201-204. 被引量:1
-
8张祥生,叶章群.微波消融联合^(125)Ⅰ及5-Fu粒子植入治疗激素难治性前列腺癌[J].临床泌尿外科杂志,2008,23(4):301-302. 被引量:4
-
9湛永滋,黄昌杰,黄剑峰.鼻内镜下^(125)I粒子植入治疗鼻咽癌放疗后鼻咽部残留病灶[J].中国内镜杂志,2008,14(5):485-486. 被引量:2
-
10袁鹤胜,程跃,李和民,任胜胜.前列腺^(125)I放射粒子植入结合去势治疗晚期前列腺癌(附16例报告)[J].现代实用医学,2008,20(12):969-970. 被引量:1
同被引文献50
-
1陈昭典.前列腺特异性抗原在前列腺癌早期诊断中的价值[J].临床外科杂志,2004,12(2):72-73. 被引量:8
-
2Schroder FH,Habbema DF,Roobol MJ,et al.Prostate cancer in the Swedish section of ERSPC-evidence for less metastases at diagnosis but not for mortality reduction.Eur Urol,2007,51:588-590.
-
3叶敏.精益求精;进一步提高我国前列腺癌的诊治水平[J].中华泌尿外科杂志,2008,29:145-152.
-
4Etzioni R,Gulati R,Falcon S,et al.Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States:a surveillance modeling approach.Med Decis Making,2008,28:323-331.
-
5Lilja H,Ulmert D,Bjork T,et al.Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.J Clin Oncol,2007,25:431-436.
-
6Korfage IJ,de Koning HJ.Habbema JD,et al.Side-effects of treatment for localized prostate cancer:are they valued differently by patients and healthy controls?BJU Int,2007,99:801-806.
-
7Schroder FH.Biomarkers and screening for prostate cancer.Ann Oncol,2006,17:201-206.
-
8Pelzer AE,Colleselli D,Bektic J,et al.Clinical and pathological features of screen vs non-screen-detected prostate cancers:is there a difference?BJU Int,2008,102:24-27.
-
9Antenor JA,Roehl KA,Eggener SE,et al.Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease.Urology,2005,66:156-160.
-
10Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008.CA Csneer J Clin,2008,58:71-96.
二级引证文献24
-
1魏雪栋,侯建全,张光波,袁和兴,黄玉华,李琛.前列腺液中B7-H3分子表达对t-PSA灰区内炎性PSA升高的鉴别诊断价值[J].中华泌尿外科杂志,2011,32(7):482-485. 被引量:1
-
2杨望君,潘美秋.前列腺特异性抗原检测在前列腺疾病中的临床应用[J].实用预防医学,2011,18(7):1341-1342.
-
3李朝伟,邬丽萍.老年前列腺癌11例误诊临床剖析[J].临床误诊误治,2011,24(9):45-46. 被引量:2
-
4李虹,张玉梅.对26例前列腺癌患者的长期随诊观察[J].中华全科医学,2011,9(12):1918-1919. 被引量:1
-
5杨鹏,王健.前列腺癌肿瘤标志物应用的研究进展[J].现代医药卫生,2012,28(8):1200-1202. 被引量:1
-
6孙建明,孙龙飞,曾向阳,许足三,李勇,李强,张伦中,徐旭红.前列腺癌根治术五例临床分析[J].海南医学,2012,23(20):114-115. 被引量:2
-
7曹璐颖,李克.前列腺癌患者血清生物标志物研究及应用进展[J].临床检验杂志,2013,31(1):44-47. 被引量:2
-
8张伟,李永忠,冯萍,袁佳英,勾忠平.应用判别分析探索不同指标对前列腺癌的诊断价值[J].华西医学,2013,28(4):563-566.
-
9王鑫,刘明,李萍,朱玲,陈鑫,万奔,王建业.北京地区50岁以上体检人群前列腺特异性抗原筛查结果分析[J].中华泌尿外科杂志,2013,34(6):462-465. 被引量:7
-
10李建军,刘胜.前列腺癌的诊断和治疗进展[J].医学综述,2013,19(20):3718-3720. 被引量:9
-
1王洪武,马洪明,罗凌飞,李红.氩氦刀联合放/化疗粒子植入治疗肺癌[J].中国肺癌杂志,2009,12(5):408-411. 被引量:7
-
2何佳恒,陈琪萍,钟文彬,李兴亮,姜林,王静.^125I种子源研究进展[J].中华临床医学杂志,2008,9(10):33-37. 被引量:2
-
3刘韬,林保和.Pd-103永久性种子植入在胰腺癌治疗中的应用[J].陕西肿瘤医学,2002,10(2):149-151.